Effectiveness of phenytoin-caffeine combination in general seizure
Phase 2
- Conditions
- Epilepsy with general seizure
- Registration Number
- JPRN-UMIN000012255
- Lead Sponsor
- Directorate General of Higher Education, Ministry of Education and Culture
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Diabetes Mellitus, acute or chronic myocard infarction, hypertension, chronic liver diseases
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seizure frequency, seizure reduction>50%, 6 month remission
- Secondary Outcome Measures
Name Time Method Plasma phenytoin concentration, and adverse drug reaction.